Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Shares Shorted: Short Interest Up 4,554.1% in October

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the recipient of a large increase in short interest during the month of October. As of October 30th, there was short interest totaling 30,112 shares, an increase of 4,554.1% from the October 15th total of 647 shares. Based on an average daily volume of 125,394 shares, the days-to-cover ratio is presently 0.2 days.

Ono Pharmaceutical Stock Performance

Shares of OPHLY stock opened at $5.06 on Wednesday. Ono Pharmaceutical has a fifty-two week low of $4.17 and a fifty-two week high of $5.75. The stock’s fifty day moving average is $5.02 and its two-hundred day moving average is $5.03.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co., Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and commercialization of prescription medicines. The company focuses on areas including oncology, immunology, neurology and other serious diseases, with an emphasis on discovering therapies that address unmet medical needs. Ono is best known for Opdivo (nivolumab), an immune checkpoint inhibitor developed in collaboration with Bristol Myers Squibb. Opdivo is used in multiple cancer indications, depending on regulatory approval in individual markets.